PERSPECTA

News from every angle

Back to headlines

Medicenna Therapeutics Reports GAAP EPS of -$0.06

Medicenna Therapeutics Corp. has released its financial results, showing a GAAP Earnings Per Share of -$0.06.

14 Aug, 14:18 — 14 Aug, 14:18
PostShare

Sources

Showing 1 of 1 sources